- Home
- AGYS vs SLNO Comparison
AGYS vs SLNO Comparison
Compare AGYS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGYS
- SLNO
- Stock Information
- Founded
- AGYS 1963
- SLNO 1999
- Country
- AGYS United States
- SLNO United States
- Employees
- AGYS N/A
- SLNO N/A
- Industry
- AGYS EDP Services
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AGYS Technology
- SLNO Health Care
- Exchange
- AGYS Nasdaq
- SLNO Nasdaq
- Market Cap
- AGYS 2.4B
- SLNO 2.3B
- IPO Year
- AGYS N/A
- SLNO 2014
- Fundamental
- Price
- AGYS $72.54
- SLNO $71.45
- Analyst Decision
- AGYS Strong Buy
- SLNO Strong Buy
- Analyst Count
- AGYS 5
- SLNO 8
- Target Price
- AGYS $133.00
- SLNO $95.75
- AVG Volume (30 Days)
- AGYS 257.2K
- SLNO 1.8M
- Earning Date
- AGYS 05-12-2025
- SLNO 05-08-2025
- Dividend Yield
- AGYS N/A
- SLNO N/A
- EPS Growth
- AGYS N/A
- SLNO N/A
- EPS
- AGYS 0.79
- SLNO N/A
- Revenue
- AGYS $263,572,999.00
- SLNO N/A
- Revenue This Year
- AGYS $17.25
- SLNO N/A
- Revenue Next Year
- AGYS $20.76
- SLNO N/A
- P/E Ratio
- AGYS $91.82
- SLNO N/A
- Revenue Growth
- AGYS 15.53
- SLNO N/A
- 52 Week Low
- AGYS $70.40
- SLNO $36.61
- 52 Week High
- AGYS $142.64
- SLNO $73.97
- Technical
- Relative Strength Index (RSI)
- AGYS 36.33
- SLNO 82.97
- Support Level
- AGYS $73.28
- SLNO $48.29
- Resistance Level
- AGYS $78.59
- SLNO $73.97
- Average True Range (ATR)
- AGYS 2.33
- SLNO 3.17
- MACD
- AGYS 0.62
- SLNO 2.71
- Stochastic Oscillator
- AGYS 26.03
- SLNO 91.28
About AGYS Agilysys Inc.
Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.